Biolegend, 400165, Ultra-LEAF™ Purified Mouse IgG1, κ Isotype Ctrl Antibody, 100μg

The MOPC-21 immunoglobulin has unknown specificity. The isotype of this antibody is mouse IgG1, κ. This antibody was chosen as an isotype control after screening on a variety of resting, activated, live, and fixed mouse, rat and human tissues.
100μg
Antibody Type: Monoclonal
Host Species: Mouse
Formulation: 0.2 µm filtered in phosphate-buffered solution, pH 7.2, containing no preservative.
Endotoxin Level: Less than 0.01 EU/µg of the protein (< 0.001 ng/µg of the protein) as determined by the LAL test.
Preparation: The Ultra-LEAF™ (Low Endotoxin, Azide-Free) antibody was purified by affinity chromatography.
Concentration: The antibody is bottled at the concentration indicated on the vial, typically between 2 mg/mL and 3 mg/mL. Older lots may have also been bottled at 1 mg/mL. To obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C. This Ultra-LEAF™ solution contains no preservative; handle under aseptic conditions.
Application: FC - Quality testedICFC, ICC, IHC, IP, WB, FA - Reported in the literature, not verified in house
Recommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis as negative control. Use at concentrations comparable to those of the specific antibody of interest.
Application Notes: Additional reported applications (for the relevant formats) include: Intracellular Flow Cytometry (ICFC), Immunocytochemistry (ICC), Immunohistochemistry (IHC), Immunoprecipitation (IP), Western Blotting (WB), Functional Assay (FA)
Application References(PubMed link indicates BioLegend citation): Carlsten M, et al. 2007. Cancer Res. 67:1317. PubMed Smed-Sörensen A, et al. 2008. Blood 111:5037. PubMed (FA) Bunesmann MM, et al. 2011. Am. J. Respir. Cell. Mol. Biol. Epub. PubMed Matsuyama T, et al. 2005. Infect. Immun. 73:1044. (IF) Correia DV, et al. 2011. Blood 118:992. (FC) PubMed Lian IA, et al. 2011. Placenta. 32:823. PubMed Bufe B, et al. 20015. J Biol Chem. 290:7369. PubMed
Product Citations: Holay N, et al. 2023. Front Immunol. 13:1047661. PubMed Henschke V, et al. 2023. iScience. 26:106352. PubMed van Delft MAM, et al. 2023. Front Immunol. 14:1118539. PubMed Nakayama K, et al. 2020. Cell Immunol. 358:104237. PubMed Gao SS, et al. 2022. iScience. 25:105481. PubMed Li H, et al. 2022. Cell Rep. 41:111834. PubMed Willcox CR, et al. 2020. Immunity. 51(5):813-825.e4.. PubMed Ding L, et al. 2021. Cancers (Basel). 13:. PubMed Junker F, et al. 2021. Cytometry A. 99:832. PubMed Donado CA, et al. 2020. Cell Reports. 31(1):107466. PubMed Schimek V, et al. 2022. Cell Death Dis. 13:113. PubMed Kim SHJ, et al. 2021. Mol Biol Cell. 32:1749. PubMed Ma YV, et al. 2021. MAbs. 13:2003281. PubMed Beatson RE, et al. 2021. Cell Rep Med. 2:100473. PubMed Sodji QH, et al. 2022. Cancer Res Commun. 2:725. PubMed Gu C, et al. 2021. Front Immunol. 12:678036. PubMed Gravastrand CS, et al. 2019. J Immunol. 203(4). PubMed Yamaguchi Y, et al. 2022. J Immunother Cancer. 10:. PubMed Kalafati L, et al. 2020. Cell. 183:771. PubMed Vazquez Rodriguez G, et al. 2020. Front Oncol. 10:598684. PubMed Guo X, et al. 2021. iScience. 24:103295. PubMed
RRID: AB_11150399 (BioLegend Cat. No. 400165) AB_11146992 (BioLegend Cat. No. 400166) AB_2927801 (BioLegend Cat. No. 400197) AB_2927801 (BioLegend Cat. No. 400198) AB_2927801 (BioLegend Cat. No. 400152) AB_2927801 (BioLegend Cat. No. 400154)
Gene ID: NA
Clone: MOPC-21
Regulatory Status: RUO
Isotype: Mouse IgG1, κ
Q: Do you guarantee that your antibodies are totally pathogen free?
A: BioLegend does not test for pathogens in-house aside from the GoInVivo™ product line. However, upon request, this can be tested on a custom basis with an outside, independent laboratory.
Q: Does BioLegend test each Ultra-LEAF™ antibody by functional assay?
A: No, BioLegend does not test Ultra-LEAF™ antibodies by functional assays unless otherwise indicated. Due to the possible complexities and variations of uses of biofunctional antibodies in different assays and because of the large product portfolio, BioLegend does not currently perform functional assays as a routine QC for the antibodies. However, we do provide references in which the antibodies were used for functional assays and we do perform QC to verify the specificity and quality of the antibody based on our strict specification criteria.
Q: Does BioLegend test each Ultra-LEAF™ antibody for potential pathogens?
A: No, BioLegend does not test for pathogens in-house unless otherwise indicated.  However, we can recommend an outside vendor to perform this testing as needed.
Q: Have you tested this Ultra-LEAF™ antibody for in vivo or in vitro applications?
A: We don't test our antibodies for in vivo or in vitro applications unless otherwise indicated. Depending on the product, the TDS may describe literature supporting usage of a particular product for bioassay. It may be best to further consult the literature to find clone specific information.